CEACAM5 and colorectal carcinoma: Another pilot study included 11 patients who received an imaging work-up for the diagnosis of metastases from CEA-expressing CRC, comprising TF2/68Ga-IMP288 immuno-PET, 18FDG-PET, thoraco-abdominopelvic CT, liver MRI, and abdominal ultrasound scanning.